Join Cognition Therapeutics at Cantor Fitzgerald Brain Week 2023: Exploring Innovative Approaches to Alzheimer’s Disease
Cognition Therapeutics Participates in Cantor Fitzgerald Brain Week 2023 Panel Purchase, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) announced today that Lisa Ricciardi, president and chief executive officer, will be participating on a panel during Cantor Fitzgerald’s virtual Brain Week 2023 conference. The event is scheduled to take place from…